Procter & Gamble Q4 sales slightly miss estimates

Overview

• U.S. consumer goods maker's Q4 sales rose 2%, slightly missing analyst expectations

• Q4 adjusted EPS beat analyst expectations, though fell 3% yr/yr

• Company cited higher SG&A and lower gross margin as weighing on Q4 profit

Outlook

• P&G expects FY 2027 all-in and organic sales growth of 1% to 3%

• Company sees FY 2027 diluted EPS growth of 1% to 5% versus FY 2026

• P&G expects FY 2027 core EPS growth of in-line to 3%, range $6.89 to $7.11

Result Drivers

• SEGMENT PERFORMANCE - Beauty segment organic sales rose, but Health Care and Baby, Feminine & Family Care segments saw declines, while other segments were largely flat

• MARGIN PRESSURE - Gross margin was weighed down by unfavorable product mix, reinvestments, and higher commodity costs, offsetting productivity savings

• HIGHER SG&A - SG&A expenses increased due to reinvestments, mainly in marketing, partially offset by productivity savings

Company press release: ID:nBw7rL94Qa

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Reuters Recommended Reads

• July 29 - Reckitt's emerging markets growth fuels sales, launches $665 million buyback

• July 28 - Oreo maker Mondelez beats second-quarter estimates on steady demand

• July 28 - Coca-Cola hails World Cup hydration breaks as it lifts annual forecasts

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)